Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells

被引:10
|
作者
Neelambaran, Nishna [1 ,2 ]
Shamjith, Shanmughan [1 ,2 ]
Murali, Vishnu Priya [1 ,2 ]
Maiti, Kaustabh Kumar [1 ,2 ]
Joseph, Joshy [1 ,2 ]
机构
[1] Natl Inst Interdisciplinary Sci & Technol CSIR NII, Chem Sci & Technol Div CSTD, Thiruvananthapuram 695019, Kerala, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
关键词
dinuclear iridium complex; reactive oxygen species (ROS); photosensitizers (PSs); photodynamic therapy (PDT); targeted therapy; apoptosis; METAL-COMPLEXES; LIVE CELL; PHOTOSENSITIZERS; METASTASIS; LYSOSOME; PROBES; AGENTS; DYES;
D O I
10.1021/acsabm.3c00883
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Photodynamic therapy (PDT) has emerged as an efficient and noninvasive treatment approach utilizing laser-triggered photosensitizers for combating cancer. Within this rapidly advancing field, iridium-based photosensitizers with their dual functionality as both imaging probes and PDT agents exhibit a potential for precise and targeted therapeutic interventions. However, most reported classes of Ir(III)-based photosensitizers comprise mononuclear iridium(III), with very few examples of dinuclear systems. Exploring the full potential of iridium-based dinuclear systems for PDT applications remains a challenge. Herein, we report a dinuclear Ir(III) complex (IRDI) along with a structurally similar monomer complex (IRMO) having 2-(2,4-difluorophenyl)pyridine and 4 '-methyl-2,2 '-bipyridine ligands. The comparative investigation of the mononuclear and dinuclear Ir(III) complexes showed similar absorption profiles, but the dinuclear derivative IRDI exhibited a higher photoluminescence quantum yield (Phi(p)) of 0.70 compared to that of IRMO (Phi(p) = 0.47). Further, IRDI showed a higher singlet oxygen generation quantum yield (Phi(s)) of 0.49 compared to IRMO (Phi(s) = 0.28), signifying the enhanced potential of the dinuclear derivative for image-guided photodynamic therapy. In vitro assessments indicate that IRDI shows efficient cellular uptake and significant photocytotoxicity in the triple-negative breast cancer cell line MDA-MB-231. In addition, the presence of a dual positive charge on the dinuclear system facilitates the inherent mitochondria-targeting ability without the need for a specific targeting group. Subcellular singlet oxygen generation by IRDI was confirmed using Si-DMA, and light-activated cellular apoptosis via ROS-mediated PDT was verified through various live-dead assays performed in the presence and absence of the singlet oxygen scavenger NaN3. Further, the mechanism of cell death was elucidated by an annexin V-FITC/PI flow cytometric assay and by investigating the cytochrome c release from mitochondria using Western blot analysis. Thus, the dinuclear complex designed to enhance spin-orbit coupling with minimal excitonic coupling represents a promising strategy for efficient image-guided PDT using iridium complexes.
引用
收藏
页码:5776 / 5788
页数:13
相关论文
共 50 条
  • [41] Fluorescence lifetime guided precision photodynamic therapy for treating tumour stem cells by a cyclometalated iridium (III) complex with free rotational pyridine units in tissue level
    Xiang, Pan
    Huang, Ridong
    Shao, Tao
    Shu, Ying
    Li, Dandan
    Zhang, Qiong
    Tian, Yupeng
    Tian, Xiaohe
    SENSORS AND ACTUATORS B-CHEMICAL, 2022, 361
  • [42] Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
    Kundu, Manjari
    Greer, Yoshimi Endo
    Dine, Jennifer L.
    Lipkowitz, Stanley
    CELLS, 2022, 11 (23)
  • [43] Establishment of Estrogen Inhibition Therapy targeting IL-34 in Triple-Negative Breast Cancer
    Kajihara, Nabeel
    Seino, Kenichiro
    CANCER SCIENCE, 2023, 114 : 1958 - 1958
  • [44] Dual stimuli-activatable versatile nanoplatform for photodynamic therapy and chemotherapy of triple-negative breast cancer
    Xu, Jie
    Lai, Yi
    Wang, Fengyang
    Zou, Zhifeng
    Pei, Renjun
    Yu, Haijun
    Xu, Zhiai
    CHINESE CHEMICAL LETTERS, 2023, 34 (12)
  • [45] Dual stimuli-activatable versatile nanoplatform for photodynamic therapy and chemotherapy of triple-negative breast cancer
    Jie Xu
    Yi Lai
    Fengyang Wang
    Zhifeng Zou
    Renjun Pei
    Haijun Yu
    Zhiai Xu
    Chinese Chemical Letters, 2023, 34 (12) : 450 - 458
  • [46] A turn-on mitochondria-targeted iridium (III) Complex-Based probe for glutathione detection and photodynamic therapy of cancer cells
    Mao, Xueting
    Fei, Xiao
    Cai, Tangxuan
    Xu, Sha
    Zhang, Daobin
    Pu, Shouzhi
    Li, Zhijian
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2025, 329
  • [47] Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
    Xia, Lin
    Zheng, Zaozao
    Liu, Jun-Yi
    Chen, Yu-Jie
    Ding, Jiancheng
    Hu, Guo-Sheng
    Hu, Ya-Hong
    Liu, Suling
    Luo, Wen-Xin
    Xia, Ning-Shao
    Liu, Wen
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (06) : 707 - 722
  • [48] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
    Li, Chia-Wei
    Lim, Seung-Oe
    Chung, Ezra M.
    Kim, Yong-Soo
    Park, Andrew H.
    Yao, Jun
    Cha, Jong-Ho
    Xia, Weiya
    Chan, Li-Chuan
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Chou, Chao-Kai
    Liu, Yen-Liang
    Yeh, Hsin-Chih
    Perillo, Evan P.
    Dunn, Andrew K.
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Huang, Tzu-Hsuan
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER CELL, 2018, 33 (02) : 187 - +
  • [49] Targeting FoxM1 in inducing anticancer effects in triple-negative breast cancer cells
    Bu, Rong
    Siraj, Abdul K.
    Ahmed, Maqbool
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2017, 77
  • [50] Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
    Abderrahim El Guerrab
    Mahchid Bamdad
    Yves-Jean Bignon
    Frédérique Penault-Llorca
    Corinne Aubel
    Scientific Reports, 10